Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Methamphetamine or Cocaine Dependence: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Methamphetamine or Cocaine Dependence: 1 US clinical trial tracked, none currently recruiting.

Methamphetamine or Cocaine Dependence is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Arkansas, running 1 of these trials.

Enrollment posture brief

Registry condition methamphetamine-or-cocaine-dependence

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Methamphetamine or Cocai (this)Methamphetamine or Cocai (th…0%
Open-enrollment share among volume-matched conditions near Methamphetamine or Cocaine Dependence

Methamphetamine or Cocaine Dependence has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Methamphetamine or Cocaine Dependence on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Methamphetamine or Cocaine Dependence is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Methamphetamine or Cocaine Dependence records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Doxazosin extended release Drug
1 trials

US sites by state

Facility locations filed on Methamphetamine or Cocaine Dependence trials. A trial with sites in several states counts in each.

Arkansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Methamphetamine or Cocaine Dependence page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Methamphetamine or Cocaine Dependence trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • University of Arkansas sponsors the most Methamphetamine or Cocaine Dependence trials on record, review their full trial history before evaluating a specific study. See University of Arkansas's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Methamphetamine or Cocaine Dependence condition card totals 1 registered trials; most-linked intervention Doxazosin extended release; top US site state Arkansas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.